- Revenue 2023
- $56,979
- Expenses 2023
- $621,890
Program services were 95.1% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
As filed
- Subsection
- 03
- NTEE code
- H90
- Classification
- 2100
- Street
- 450 DULEY RD
These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).
Mission and programs · 2023
Mission
THE SPECIFIC AND PRIMARY PURPOSE OF THIS ORGANIZATION IS TO ENGAGE IN THE CONTINUOUS ACTIVE CONDUCT OF MEDICAL RESEARCH IN CONJUNCTION WITH ONE OR MORE HOSPITALS WHICH ARE DESCRIBED IN SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE, ARE FEDERAL HOSPITALS, OR ARE INSTRUMENTALITIES OF A GOVERNMENTAL UNIT REFERRED TO IN SECTION 170(C)(1) OF THE INTERNAL REVENUE CODE. THE ORGANIZATION IS DEDICATED TO RESEARCH AND TECHNOLOGY DEVELOPMENT IN PERSONALIZED MOLECULAR MEDICINE FOR THE TREATMENT OF UNMET MEDICAL NEEDS. PERSONALIZED MOLECULAR MEDICINE PROVIDES CUSTOMIZATION OF HEALTHCARE, WITH DECISIONS AND PRACTICES BEING TAILORED TO INDIVIDUAL PATIENTS AT THE MOLECULAR LEVEL.
Activities or mission (Part I)
THE SPECIFIC AND PRIMARY PURPOSE OF THIS ORGANIZATION IS TO ENGAGE IN THE CONTINUOUS ACTIVE CONDUCT OF MEDICAL RESEARCH IN CONJUNCTION WITH ONE OR MORE HOSPITALS.
-
THE ORGANIZATION IS DIRECTLY ENGAGED IN THE CONTINUOUS ACTIVE CONDUCT OF MEDICAL RESEARCH IN CONJUNCTION WITH VARIOUS CLINICAL SETTINGS AND HOSPITALS. INITIALLY, THE ORGANIZATION WAS ENGAGED IN A JOINT EFFORT WITH PROVIDENCE SAINT JOHN'S HEALTH CENTER TO CONDUCT RESEARCH AND DEVELOPMENT OF PERSONALIZED MOLECULAR MEDICAL THERAPIES FOR THE TREATMENT OF UNMET MEDICAL NEEDS. CURRENTLY, THE ORGANIZATION IS ENGAGED IN JOINT EFFORTS WITH WINDBER HOSPITAL AND JOHNS HOPKINS UNIVERSITY TO CONDUCT PARALLEL RESEARCH AND DEVELOPMENT. THE ORGANIZATION PROVIDES FUNDING, DATA AND EXPERTISE AND PERFORMS SUPPORT SERVICES INCLUDING, WITHOUT LIMITATION, CUSTOM ENGINEERING, REGULATORY AND MEDICAL SUPPORT SERVICES FOR EACH PROJECT CONDUCTED THROUGH ITS JOINT EFFORTS WITH WINDBER HOSPITAL AND JOHNS HOPKINS UNIVERSITY. THE ORGANIZATION ALSO PLANS TO CONDUCT MEDICAL RESEARCH PROJECTS IN COLLABORATION WITH VARIOUS UNIVERSITIES, PARTICULARLY RESEARCH PROJECTS LED BY FACULTY OF THE UNIVERSITY OF CALIFORNIA AND PARTNER INSTITUTIONS. THE ORGANIZATION WILL ANNUALLY EXPEND FUNDS EQUAL TO 3.5% OR MORE OF THE FAIR MARKET VALUE OF ITS ENDOWMENT FOR THE CONTINUOUS CONDUCT OF MEDICAL RESEARCH OR WILL DEVOTE MORE THAN ONE HALF OF ITS ASSETS TO THE CONTINUOUS CONDUCT OF MEDICAL RESEARCH. THE ORGANIZATION HAS CONTRACTED WITH CHAN SOON-SHIONG INSTITUTE OF MOLECULAR MEDICINE AT WINDBER TO STUDY THE LONG-TERM EFFECTS OF COVID-19 IN BREAST CANCER PATIENTS. THE STUDY INVOLVES OVER 400 PARTICIPANTS. BREAST CANCER IS A COMMON CANCER IN WOMEN WITH 685,000 WORLDWIDE DEATHS IN THE YEAR 2020 ALONE. APPROXIMATELY 30% OF ALL NEW FEMALE CANCERS ARE BREAST CANCER. MANY OF THE ESTABLISHED RISK FACTORS ARE LINKED TO ESTROGEN. RISK IS INCREASED BY BEGINNING MENSTRUATION AT A YOUNG AGE, ENTERING MENOPAUSE LATER IN LIFE, AND OBESITY IN POSTMENOPAUSAL WOMEN. THE PHYSIOLOGICAL ENVIRONMENT THAT STIMULATES SOMATIC CELLS PROLIFERATION AND DIFFERENTIATION LEADING TO CARCINOMA ARE NOT WELL UNDERSTOOD. THE RELATIONSHIP BETWEEN INFLAMMATION AND CANCER IS EMERGING. INFLAMMATORY DISEASES INCREASE THE RISK OF DEVELOPING CANCER. PLASMA FROM PARTICIPANTS IN THE STUDY WHO HAD COVID-19 OR NOT WILL BE UTILIZED TO UNDERSTAND THE ANTI-INFLAMMATORY IMMUNE RESPONSE IN PATIENTS WITH PREVIOUS BREAST CANCER DIAGNOSIS AND COMPARE WITH PARTICIPANTS WITH NO PREVIOUS CANCER DIAGNOSIS (CONTROLS). THE HYPOTHESIS IS THAT THE INCREASED IMMUNE RESPONSE TO COVID-19 RESULTS IN A CHRONIC IMMUNE RESPONSE IN THE BREAST CHANGING THE MICROENVIRONMENT FROM AT TH1 RESPONSE TO A TH2 RESPONSE WHICH RESULTS IN MORE AGGRESSIVE BREAST CANCER. THE STUDY IS ONGOING AND SIGNIFICANT FINDINGS WILL BE PUBLISHED UPON COMPLETION.
Expenses $591,273 · Grants $160,000
As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.
Officers and directors · 2023
As listed in Part VII of the 2023 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.
-
PHILLIP B GORDON
DIRECTOR OF GOVT. RELATIONS
- Total calculated
- $321,442
- From this org
- $278,183
- From related orgs
- $0
- Other
- $43,259
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $278,183
- Bonus
- not reported
- Other
- not reported
- Deferred
- $27,059
- Nontaxable benefits
- $16,200
- Filer's total
- $321,442
-
PATRICK SOON-SHIONG
PRESIDENT, DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
MICHELE B SOON-SHIONG
TREASURER, DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
LEONARD SHAPIRO
DIRECTOR, SECRETARY
- Total calculated
- $0
- Hours/week
- 0
-
MICHAEL SITRICK
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.
Filings
-
2023
- Revenue
- $56,979
- Expenses
- $621,890
- Contributions
- $0
- Grants paid
- $160,000
-
2022
- Revenue
- $65,306
- Expenses
- $716,071
- Contributions
- $0
- Grants paid
- $210,000
The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.
Other returns filed
-
2021 · 990
- Revenue
- $49,958
- Expenses
- $1,093,609
- Assets (EOY)
- $23,830,252
-
2020 · 990
- Revenue
- $63,681
- Expenses
- $483,866
- Assets (EOY)
- $24,916,368
-
2019 · 990
- Revenue
- $158,262
- Expenses
- $1,687,532
- Assets (EOY)
- $25,380,484
-
2018 · 990
- Revenue
- $1,678,702
- Expenses
- $4,938,497
- Assets (EOY)
- $26,914,279
-
2017 · 990
- Revenue
- $254,616
- Expenses
- $9,152,816
- Assets (EOY)
- $35,744,374
-
2016 · 990
- Revenue
- $1,577,074
- Expenses
- $8,539,933
- Assets (EOY)
- $42,139,233
-
2015 · 990
- Revenue
- -$221,358
- Expenses
- $3,565,440
- Assets (EOY)
- $43,665,883
-
2014 · 990
- Revenue
- $2,766,087
- Expenses
- $19,841,008
- Assets (EOY)
- $47,794,094
Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all.
Grants made
-
$210,000
2022 RESEARCH ON MOLECULAR DIAGNOSTIC/PROGNOSTIC BIOMARKERS
-
$160,000
2023 RESEARCH ON MOLECULAR DIAGNOSTIC/PROGNOSTIC BIOMARKERS
Grants received
No itemized grant names this organization as a recipient. Only grants over $5,000 are itemized, and only by filers of the full Form 990.
Related organizations
From Schedule R Part II, where a filer lists the tax-exempt organizations it is related to by control. It does not record shared board members or money.
Declared on its 2023 return
-
CHAN SOON-SHIONG FAMILY FOUNDATION
501(C)(3) · GRANTS · CA
-
501(C)(3) · HEALTHCARE · PA
-
WINDBER HEALTH CARE FOUNDATION INC
501(C)(3) · FUNDRAISING · PA
-
WINDBER HOSPITAL PALLIATIVE CARE FDTN
501(C)(3) · FUNDRAISING · PA
-
501(C)(3) · RESEARCH · PA
-
Foundation for Translation Science
501(c)(3) · Grants · CA
Declared as related by
-
WINDBER HEALTH CARE FOUNDATION INC
On its 2024 return
-
On its 2024 return
Taxable family
From Schedule R Parts I, III and IV: entities that legally are the filer, and taxable partnerships, corporations and trusts it is related to. These record ownership and control, not shared board members or money.
Disregarded entities on its 2023 return
-
CHAN SOON-SHIONG INSTITUTE OF MOLECULAR
MED. RESEARCH · DE · assets $22,242
Related partnerships on its 2023 return
-
MULTIPLE - DETAILS AVAILABLE
DETAILS AVAIL · DE
Related corporations and trusts on its 2023 return
-
MULTIPLE - DETAILS AVAILABLE
C CORP · DETAILS AVAIL · DE
-
MULTIPLE - DETAILS AVAILABLE
TRUSTS · INVESTING · DE
-
C CORP · REAL ESTATE R · PA · 100% owned
Other IRS files
Auto-Revocation List
Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.
Publication 78
Listed as of 13 October 2026, under deductibility PC.
These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.
What this page reflects
The registration facts above come from the IRS Business Master File published 13 October 2026 and read 29 October 2026, for every organization at once. Returns through tax year 2023, the newest we have parsed for this organization.